GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
Pakistan · Delayed Price · Currency is PKR 337.31
-2.70 (-0.79%)
At close: Nov 6, 2026
GlaxoSmithKline Pakistan Financials Overview
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 69,525 | 65,901 | 61,188 | 49,661 | 41,842 | 36,661 |
Revenue Growth | 12.00% | 7.70% | 23.21% | 18.69% | 14.13% | 4.48% |
Gross Profit Gross Profit Growth | 26,774 | 24,283 | 15,277 | 3,416 | 7,336 | 9,874 |
Operating Income Operating Income Growth | 18,003 | 16,360 | 10,252 | 1,965 | 5,068 | 6,873 |
Net Income Net Income Growth | 10,984 | 10,025 | 6,536 | 533.95 | 2,463 | 5,354 |
Earnings Per Share EPS Growth | 34.49 | 31.48 | 20.52 | 1.68 | 7.73 | 16.81 |
EPS Growth | 19.54% | 53.39% | 1124.09% | -78.32% | -54.00% | 58.64% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pakistan Pakistan Growth | 66,444 | 62,218 | 51,742 | 44,270 | 38,119 |
Export Export Growth | 13.46 | 15.86 | - | 26.47 | 28.88 |
Unallocated Commissions, Returns and Discounts Unallocated Commissions, Returns and Discounts Growth | 98.99 | -417.03 | -1,584 | - | - |
Unallocated Sales Tax Unallocated Sales Tax Growth | -655.48 | -628.93 | -496.75 | - | - |
Total Total Growth | 65,901 | 61,188 | 49,661 | 41,842 | 36,661 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 8,145 | 8,592 | 6,513 | 3,611 | 4,755 | 8,719 |
Total Debt Total Debt Growth | 337.98 | 614.63 | 372.28 | 724.9 | 346.07 | 289.36 |
Net Cash (Debt) Net Cash Growth | 7,807 | 7,978 | 6,141 | 2,886 | 4,408 | 8,429 |
Net Cash Growth | 17.58% | 29.90% | 112.80% | -34.54% | -47.70% | 48.37% |
Net Cash Per Share Net Cash Per Share Growth | 24.52 | 25.05 | 19.28 | 9.06 | 13.84 | 26.47 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 8,595 | 8,664 | 5,058 | 1,884 | -3,161 | 4,987 |
Capital Expenditures CapEx Growth | -2,287 | -2,583 | -2,775 | -1,649 | -1,533 | -1,304 |
Free Cash Flow Free Cash Flow Growth | 6,307 | 6,081 | 2,282 | 234.56 | -4,694 | 3,683 |
Free Cash Flow Growth | 44.10% | 166.44% | 873.04% | - | - | -20.69% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 38.51% | 36.85% | 24.97% | 6.88% | 17.53% | 26.93% |
Operating Margin | 25.89% | 24.82% | 16.75% | 3.96% | 12.11% | 18.75% |
Pretax Margin | 26.48% | 25.32% | 17.12% | 4.38% | 12.20% | 20.25% |
Profit Margin | 15.80% | 15.21% | 10.68% | 1.07% | 5.89% | 14.61% |
FCF Margin | 9.07% | 9.23% | 3.73% | 0.47% | -11.22% | 10.05% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 19.000 | 17.000 | 10.000 | - | - | 7.000 |
Dividend Per Share Growth | 26.67% | 70.00% | - | - | - | 7.69% |
Dividend Yield | 5.63% | 4.36% | 2.52% | - | - | 5.13% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.78 | 12.38 | 19.34 | 49.50 | 11.35 | 8.12 |
Forward PE | 9.77 | 10.86 | - | - | - | - |
P/FCF Ratio | 17.19 | 20.41 | 55.38 | 112.68 | - | 11.80 |
PS Ratio | 1.56 | 1.88 | 2.07 | 0.53 | 0.67 | 1.19 |